Pharmaceutical Industry: August Investment Strategies Focus On Performance, Faster Growth Companies

7 broader market slightly higher, at 24 July, the Shanghai index rose 6.38%

, Shenzhen index rose 6.78%. Over the same period, the pharmaceutical industry index rose 11.35%, or slightly larger than the market index to rise, from a longer view, the pharmaceutical industry's market performance is also better than the broader market's performance, the Shanghai A share index was down 18.35 for three months %, the pharmaceutical industry composite index fell 3.94 percent just three months; Shanghai A share index was down 32.51 percent for six months, the pharmaceutical industry composite index fell 22.29% for six months.

7 months, pharmaceutical industry, Medical Devices Sub-sector market, the best performance, followed by bio-pharmaceutical sub-sector. In the specific listed companies, a number of substantial growth in the medium-term performance of companies and pre-sales of better market performance of listed companies.

Level from the valuation perspective, the valuation of the pharmaceutical industry has a premium; view of this characteristic stable growth industry that the pharmaceutical industry's market performance in August will continue to outperform, continue to enjoy a certain valuation premium.

Expected in August, the performance of the pharmaceutical market will still be divided. Sub-sector, with the interim results are announced, some of API Significant sub-sector growth performance of listed companies, which trade on the bulk drug sub-market performance will be a certain stimulus. Specific listed companies, the proposed interim results concern faster growth, reasonable valuations of listed companies.

Part of the focus on the financial index of listed companies and investment ratings

One important event in the industry and listed companies

1.1 event: Xinhua Daily reported on July 9, Pfizer became the first violation, "the Clean Air Act" (CleanAirAct) and the U.S. Justice Department punished the pharmaceutical companies. It is reported that Pfizer has agreed to pay 975,000 U.S. dollars in civil penalties to resolve violations of Connecticut, Groton plant, "the Clean Air Act," was the allegation that the factory was closed in January this year, which is to strengthen the pharmaceutical companies control hazardous air pollutants After the implementation of new regulations the first case.

Pfizer breach PharmaMACT (up to control technology) provides prosecuted, in accordance with the regulations, companies must apply specific measures to avoid harm to human health or environmental pollution. Ministry of Justice said the allegations, Oct. 2002 ~ December 2005, the Pfizer Groton plant because of "missed and repair procedures," cause errors.

Ministry of Environment and Natural Resources United States officials have said the case was issued by the pharmaceutical industry, a strong signal that the pharmaceutical companies need to strengthen the detection of dangerous goods and repair work, because regulators would not wait until damage occurred after the law enforcement.

Comments: the pharmaceutical industry has been the objective of pollution. Statistics show that the pharmaceutical industry accounted for 1.7% of national industrial output value, while accounting for 2% of the sewage, the pharmaceutical industry created the "three wastes" large, complex waste composition, a serious pollution hazard. Since 2007, environmental violation after another raw material pharmaceutical companies, some pharmaceutical companies gathered in areas such as raw materials Jiaojiang Taizhou, Shaoxing Xinchang, Chengdu became contaminated Pengzhou is the hardest hit.

Pharmaceutical industry in China have been included in the national environmental management plans should focus on one of the 12 industries. SEPA published in 6066 focused on industrial pollution control companies, Pharmaceutical Industry Accounted for 117, Green is one of China's pharmaceutical enterprises are facing important issues, on the competitive landscape of China pharmaceutical industry had an important impact, will be actively concerned about the environmental policies impact on the pharmaceutical industry.

1.2 Event: July 9 suspected death caused by 6 thousand users, liberal arts "problem drugs" has been significant progress in the investigation. July 8, the State Food and Drug Administration spokeswoman Yan Jiangying said the Pharmaceutical and Biological Products of the liberal arts censorship "problem drug" sample examination revealed abnormal, and the sample can be determined by results in patients with abnormal and dead are directly related.

Pharmaceutical Industry: August Investment Strategies Focus On Performance, Faster Growth Companies

By: weihua

POST COMMENT

How to Get a MacBook Without Having to Pay for It Airsoft Machine Guns - A Look At The Echo 1 Model 249 Para Airsoft Machine Gun A Rapid Guide To Determining On The Canadian Pharmacy The Magical Performance Of Machine Espresso Breville The Magical Effect Of The Breville Espresso Machine Cone Crusher - broken machine industry outstanding in the field Information About Macha Tea Drum Beat Machine Vertical Spread - My Monthly Atm Machine Is Acid Reflux Your Stomach Pain Sobre El Paradigma O La Transformación De La Mirada Easy tricks to tone stomach What To Try To Find In A Canadian Pharmacy